Invuity, Inc. (NASDAQ:IVTY) was the recipient of a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 1,011,546 shares, a growth of 49.3% from the July 31st total of 677,615 shares. Approximately 8.5% of the shares of the company are sold short. Based on an average daily trading volume, of 200,883 shares, the days-to-cover ratio is presently 5.0 days.

Several institutional investors have recently bought and sold shares of IVTY. UBS Group AG raised its position in Invuity by 53.4% in the first quarter. UBS Group AG now owns 13,200 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 4,594 shares during the period. Citadel Advisors LLC bought a new position in Invuity during the second quarter valued at approximately $101,000. Bank of Montreal Can bought a new position in Invuity during the first quarter valued at approximately $112,000. Boston Advisors LLC bought a new position in Invuity during the first quarter valued at approximately $144,000. Finally, Renaissance Technologies LLC bought a new position in Invuity during the first quarter valued at approximately $151,000. 68.25% of the stock is owned by institutional investors.

A number of research analysts recently issued reports on IVTY shares. Northland Securities restated a “buy” rating and set a $13.00 price target on shares of Invuity in a research note on Monday, May 8th. William Blair restated a “buy” rating on shares of Invuity in a research note on Tuesday, May 23rd. Zacks Investment Research upgraded Invuity from a “sell” rating to a “hold” rating in a research note on Thursday, May 25th. Piper Jaffray Companies restated a “buy” rating and set a $10.00 price target on shares of Invuity in a research note on Wednesday, July 26th. Finally, ValuEngine upgraded Invuity from a “strong sell” rating to a “sell” rating in a research note on Friday. Two investment analysts have rated the stock with a sell rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $13.20.

Shares of Invuity (NASDAQ:IVTY) opened at 8.30 on Friday. Invuity has a 52-week low of $4.50 and a 52-week high of $14.00. The firm’s market capitalization is $141.52 million. The firm’s 50-day moving average price is $7.17 and its 200-day moving average price is $7.65.

Invuity (NASDAQ:IVTY) last posted its earnings results on Tuesday, July 25th. The medical instruments supplier reported ($0.61) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.54) by $0.07. The company had revenue of $9.77 million for the quarter, compared to the consensus estimate of $10.30 million. Invuity had a negative net margin of 114.61% and a negative return on equity of 140.69%. On average, equities analysts predict that Invuity will post ($2.38) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Invuity, Inc. (IVTY) Short Interest Update” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.watchlistnews.com/invuity-inc-ivty-short-interest-update/1537241.html.

Invuity Company Profile

Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.

Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.